227 related articles for article (PubMed ID: 15060136)
1. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.
Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK
Mol Cell Biol; 2004 Apr; 24(8):3125-31. PubMed ID: 15060136
[TBL] [Abstract][Full Text] [Related]
2. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
3. Of mice and MEN1: Insulinomas in a conditional mouse knockout.
Crabtree JS; Scacheri PC; Ward JM; McNally SR; Swain GP; Montagna C; Hager JH; Hanahan D; Edlund H; Magnuson MA; Garrett-Beal L; Burns AL; Ried T; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Mol Cell Biol; 2003 Sep; 23(17):6075-85. PubMed ID: 12917331
[TBL] [Abstract][Full Text] [Related]
4. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
[TBL] [Abstract][Full Text] [Related]
5. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.
Harding B; Lemos MC; Reed AA; Walls GV; Jeyabalan J; Bowl MR; Tateossian H; Sullivan N; Hough T; Fraser WD; Ansorge O; Cheeseman MT; Thakker RV
Endocr Relat Cancer; 2009 Dec; 16(4):1313-27. PubMed ID: 19620250
[TBL] [Abstract][Full Text] [Related]
8. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
Fontanière S; Casse H; Bertolino P; Zhang CX
Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
[TBL] [Abstract][Full Text] [Related]
11. Lack of MEN1 gene mutations in 27 sporadic insulinomas.
Cupisti K; Höppner W; Dotzenrath C; Simon D; Berndt I; Röher HD; Goretzki PE
Eur J Clin Invest; 2000 Apr; 30(4):325-9. PubMed ID: 10759881
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
Kameya T; Tsukada T; Yamaguchi K
Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype analysis in multiple endocrine neoplasia type 1.
Kouvaraki MA; Lee JE; Shapiro SE; Gagel RF; Sherman SI; Sellin RV; Cote GJ; Evans DB
Arch Surg; 2002 Jun; 137(6):641-7. PubMed ID: 12049533
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
16. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.
Shi K; Parekh VI; Roy S; Desai SS; Agarwal SK
Endocr Relat Cancer; 2013 Feb; 20(1):111-22. PubMed ID: 23419452
[TBL] [Abstract][Full Text] [Related]
17. Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor.
Ishida E; Yamada M; Horiguchi K; Taguchi R; Ozawa A; Shibusawa N; Hashimoto K; Satoh T; Yoshida S; Tanaka Y; Yokota M; Tosaka M; Hirato J; Yamada S; Yoshimoto Y; Mori M
Endocr J; 2011; 58(4):287-96. PubMed ID: 21441703
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
20. The MEN1 gene and pituitary tumours.
Agarwal SK; Ozawa A; Mateo CM; Marx SJ
Horm Res; 2009 Apr; 71 Suppl 2(Suppl 2):131-8. PubMed ID: 19407509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
